HAVN Life Sciences Inc.
HAVN
Rangering i aksjer
#38566
HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and... HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.
Aksjekurs
$0.02201811
Sist synkronisert: 2024-07-23
Markedsverdi
$847.02K
Endring (1 dag)
-0.22%
Endring (1 år)
21,918.11%
Land
CA
Handel HAVN Life Sciences Inc. (HAVN)
Kategori
Healthcare
Aksjeprishistorikk for HAVN Life Sciences Inc. (HAVN)
Høyeste sluttskurs: $0.00 den 2026-10-01
Laveste sluttskurs: $20.74 den 2020-10-01
Laveste sluttskurs: $20.74 den 2020-10-01
Aksjeprishistorikk for HAVN Life Sciences Inc. fra 2020 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -78.42% |
| 2024 | -84.57% |
| 2023 | -46.81% |
| 2022 | -98.79% |
| 2021 | -81.70% |
| 2020 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $532.09 | 24.77% |
US
|
|
| $236.63 | 781.30% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $889.94 | 9.31% |
NL
|
|
| $291.42 | 2.39% |
BE
|
